In Silico Prediction of a Multitope Vaccine against Moraxella catarrhalis: Reverse Vaccinology and Immunoinformatics
- PMID: 34207238
- PMCID: PMC8234879
- DOI: 10.3390/vaccines9060669
In Silico Prediction of a Multitope Vaccine against Moraxella catarrhalis: Reverse Vaccinology and Immunoinformatics
Abstract
Moraxella catarrhalis (M. catarrhalis) is a Gram-negative bacterium that can cause serious respiratory tract infections and middle ear infections in children and adults. M. catarrhalis has demonstrated an increasing rate of antibiotic resistance in the last few years, thus development of an effective vaccine is a major health priority. We report here a novel designed multitope vaccine based on the mapped epitopes of the vaccine candidates filtered out of the whole proteome of M. catarrhalis. After analysis of 1615 proteins using a reverse vaccinology approach, only two proteins (outer membrane protein assembly factor BamA and LPS assembly protein LptD) were nominated as potential vaccine candidates. These proteins were found to be essential, outer membrane, virulent and non-human homologs with appropriate molecular weight and high antigenicity score. For each protein, cytotoxic T lymphocyte (CTL), helper T lymphocyte (HTL) and B cell lymphocyte (BCL) epitopes were predicted and confirmed to be highly antigenic and cover conserved regions of the proteins. The mapped epitopes constituted the base of the designed multitope vaccine where suitable linkers were added to conjugate them. Additionally, beta defensin adjuvant and pan-HLA DR-binding epitope (PADRE) peptide were also incorporated into the construct to improve the stimulated immune response. The constructed multitope vaccine was analyzed for its physicochemical, structural and immunological characteristics and it was found to be antigenic, soluble, stable, non-allergenic and have a high affinity to its target receptor. Although the in silico analysis of the current study revealed that the designed multitope vaccine has the ability to trigger a specific immune response against M. catarrhalis, additional translational research is required to confirm the effectiveness of the designed vaccine.
Keywords: Moraxella catarrhalis; epitope mapping; immunoinformatics; multitope vaccine; reverse vaccinology; vaccinomics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8234879/bin/vaccines-09-00669-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8234879/bin/vaccines-09-00669-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8234879/bin/vaccines-09-00669-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8234879/bin/vaccines-09-00669-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8234879/bin/vaccines-09-00669-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8234879/bin/vaccines-09-00669-g006.gif)
Similar articles
-
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria.Vaccines (Basel). 2023 Jul 20;11(7):1264. doi: 10.3390/vaccines11071264. Vaccines (Basel). 2023. PMID: 37515079 Free PMC article. Review.
-
In silico Designing of an Epitope-Based Vaccine Against Common E. coli Pathotypes.Front Med (Lausanne). 2022 Mar 4;9:829467. doi: 10.3389/fmed.2022.829467. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35308494 Free PMC article.
-
Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.Microb Pathog. 2021 Oct;159:105150. doi: 10.1016/j.micpath.2021.105150. Epub 2021 Aug 20. Microb Pathog. 2021. PMID: 34425197
-
Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.Infect Genet Evol. 2017 Nov;55:151-158. doi: 10.1016/j.meegid.2017.09.015. Epub 2017 Sep 14. Infect Genet Evol. 2017. PMID: 28919551
-
Vaccine targets against Moraxella catarrhalis.Expert Opin Ther Targets. 2016;20(1):19-33. doi: 10.1517/14728222.2015.1081686. Epub 2015 Aug 26. Expert Opin Ther Targets. 2016. PMID: 26565427 Free PMC article. Review.
Cited by
-
Designing a multi-epitope vaccine against Shigella dysenteriae using immuno-informatics approach.Front Genet. 2024 May 17;15:1361610. doi: 10.3389/fgene.2024.1361610. eCollection 2024. Front Genet. 2024. PMID: 38826807 Free PMC article.
-
Otitis media: recent advances in otitis media vaccine development and model systems.Front Microbiol. 2024 Jan 24;15:1345027. doi: 10.3389/fmicb.2024.1345027. eCollection 2024. Front Microbiol. 2024. PMID: 38328427 Free PMC article. Review.
-
Prediction of an immunogenic peptide ensemble and multi-subunit vaccine for Visceral leishmaniasis using bioinformatics approaches.Heliyon. 2023 Nov 14;9(12):e22121. doi: 10.1016/j.heliyon.2023.e22121. eCollection 2023 Dec. Heliyon. 2023. PMID: 38196838 Free PMC article.
-
Complement System Inhibitory Drugs in a Zebrafish (Danio rerio) Model: Computational Modeling.Int J Mol Sci. 2023 Sep 9;24(18):13895. doi: 10.3390/ijms241813895. Int J Mol Sci. 2023. PMID: 37762197 Free PMC article.
-
Conserved Domains in Variable Surface Lipoproteins A-G of Mycoplasma hyorhinis May Serve as Probable Multi-Epitope Candidate Vaccine: Computational Reverse Vaccinology Approach.Vet Sci. 2023 Sep 5;10(9):557. doi: 10.3390/vetsci10090557. Vet Sci. 2023. PMID: 37756079 Free PMC article.
References
-
- Perez A.C., Pang B., King L.B., Tan L., Murrah K.A., Reimche J.L., Wren J.T., Richardson S.H., Ghandi U., Swords W.E. Residence ofStreptococcus pneumoniaeandMoraxella catarrhaliswithin polymicrobial biofilm promotes antibiotic resistance and bacterial persistencein vivo. Pathog. Dis. 2014;70:280–288. doi: 10.1111/2049-632X.12129. - DOI - PMC - PubMed
-
- Bertot G.M., Becker P.D., Guzmán C., Grinstein S. Intranasal Vaccination with Recombinant P6 Protein and Adamantylamide Dipeptide as Mucosal Adjuvant Confers Efficient Protection against Otitis Media and Lung Infection by Nontypeable Haemophilus influenzae. J. Infect. Dis. 2004;189:1304–1312. doi: 10.1086/382508. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials